We are engaged in the fight against cancer.
At Cellda (formerly MM18 Medical) we focus on digital pathology and computer assisted analysis of tissue sections of human cancer, initially prostate cancer.
Globally prostatic adenocarcinoma is the second most frequent malignancy after lung cancer in men, about 1,300,000 cases and causing about 360,000 deaths per year. Accurate histological diagnosis of prostatic adenocarcinoma is an important issue worldwide.
Our aim is to obtain reproducible, correct and objective histo-pathological diagnoses replacing microscopic examinations.
Our product CelldaTM offers clearer indication of pre cancer stages.
It also reduces intra- and interobserver variability in lab results to better serve the remitting urologist. The method also reduces overall costs and avoids under- and over-diagnosis.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Uppsala, Se
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.cellda.com
- Keywords
- MedTech, Prostate cancer, Computer assisted diagnostics, AI, Digital pathology, Biopsy, Image analysis, Diagnostic, Software, Adenocarcinoma, LGPIN, HGPIN, Antibody, Microscopy, Scanning, Medical tissue, Automatic, Research, Medical device.
- HQ
- Uppsala
Cellda Ab Questions
Cellda Ab's website is http://www.cellda.com
Cellda Ab's LinkedIn profile is https://se.linkedin.com/company/cellda
Cellda Ab has
4 employees.
View email and phone details for 4
employees at Cellda Ab.
Cellda Ab's industry is
Medical Equipment Manufacturing
Cellda Ab's top competitors are
Stardots,
Biocell Analytica,
Arguseye,
Enaiblers,
Phenaros,
Readily Diagnostics,
Mycural Therapeutics,
Caire Tech,
Rarity Bioscience,
Strike Pharma Ab.
Cellda Ab's categories are Medical Equipment Manufacturing
Cellda Ab's founding year is 2018
